Published 3 days ago • loading... • Updated 2 days ago

Atrandi Biosciences Raises $25M in Series A Funding

Summary by FinSMEs

Atrandi Biosciences, a Vilnius, Lithuania-based life sciences company advancing new single-cell analysis technology, raised $25M in Series A funding. The round was led by Lux Capital, with participation from Vsquared Ventures, Practica Capital, Metaplanet and GRIDS Capital. The company intends to use the funds to accelerate its expansion into the U.S. market, support the growth […] The post Atrandi Biosciences Raises $25M in Series A Funding app…

2 Articles

All

Left

Center

Right

GEN - Genetic Engineering and Biotechnology News…

Atrandi Raises $25M to Develop New Products Based on Semi-Permeable Capsule Tech

Atrandi Biosciences has raised $25 million in a Series A funding round led by Lux Capital, with participation from Vsquared Ventures, Practica Capital, Metaplanet, and CRIDS Capital. The company plans to use the funds to develop new products based on its semi-permeable capsule (SPC) technology as well as to set up an office in Boston which will allow the company to better serve its U.S. customer base. Atrandi, which means “you discover” in Lith…

2 days ago

Read Full Article